CliniTouch Vie 2 creates a 24/7 accessible virtual clinic providing monitoring, chronic disease management and education to patients, all within a mobile device and all at home. Clinicians are provided with real-time visibility of their most at-risk patients through an enhanced system that provides advanced warning of when a patient’s condition is likely to deteriorate by vital signs monitoring and poor air quality - enabling prompt pre-emptive interventions from the patient and the healthcare practitioner.
Users and their needs
CliniTouch Vie 2 is a flexible, real-time remote monitoring solution that is integrated into a live clinical setting across sectors to provide personalised digital solutions that empower patients and improve clinical outcomes. It provides the digital leverage to enable patients to take a more active role in their own health and care while creating capacity to increase workforce productivity to meet rising demands.
- Reduce hospital admissions – through real time management of high-risk patients preventing admissions
- Deliver workload efficiencies – support better patient self-management, reduce the need for direct interventions and enable staff to focus on priority patient care
- Support early discharge – provide hospital level diagnostics and monitoring in the home enabling early discharge and remote clinical support post-surgery or in care-home settings
- Enhance care for patients with chronic conditions – Inform and engage patients as part of NHS prevention agenda
- Offer locality wide cost savings – improve outcomes across multi-disciplinary teams
Provision of accurate, location-based satellite air quality data enhances care provision and patient self-management options.
preview of the CTV2 user interface
Service/ system concept
CliniTouch Vie 2 provides fast, simple and easy to use satellite air quality data to the digital remote monitoring system. This information helps a patient make health care decisions, such as, ‘The air quality is so poor today I will stay at home and close my windows’. Through real time monitoring, health care management and meaningful education to patients such as ‘ How to get the most out of your inhaler treatment’ or ‘Exercise for COPD patients to take outside when the air quality is good’, clinicians have an unprecedented real-time visibility of their most at-risk patients and those patients who through empowerment and intervention are being managed at home and avoiding the revolving door of hospital admissions.
Space Added Value
A number of Earth Observation data will provide inputs for the provision of the service. For instance:
▪ Data from the Copernicus Atmosphere Monitoring Service (CAMS) will be used for a range of species including NO2, O3, PM2.5 and PM10. These inputs will be critical to informing surface concentrations of key pollutants.
▪ Direct L3 NO2 data from Sentinel 5P can enhance regional import estimates within the air quality modelling.
▪ Meteorological data (EUMETSAT via ECMWF) contributes vital wind vector information to enable pollution dispersion to be accurately calculated
▪ A satellite-enhanced digital elevation model is used to provide surface feature information (including buildings and trees)
In addition, GNSS data is used for location tracking for both patients and mobile air quality sensors, and provides tailored position-based information on pollution concentrations
The Critical Design Review was successfully held and concluded at ESA/ECSAT (UK) on 21 January 2020, following presentations from stakeholders on the work and progress to date. Clinical workshops were held as part of the users’ requirements gathering and consolidation. These findings have been used to help create user stories which will be used for the service validation campaign.
Patient engagement took place both at patient’s homes and on the phone, which has provided valuable insight for CTV2 development. Regulatory and Governance Best Practice has been implemented with several meetings between Spirit Governance Team and Project Team to ensure technical file requirements are being met and all relevant documentation process is in place. The latest project documents have been updated, presented and discussed with ESA. The Project Plan is being implemented and progress is on target. The stakeholders are now turning their attention to complete the requirements for the Factory Acceptance Test, which is expected to take place during the second quarter of 2020.